+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Opiate receptor interactions of benzomorphans in rat brain homogenates

Opiate receptor interactions of benzomorphans in rat brain homogenates

Journal of Pharmacology and Experimental Therapeutics 196(2): 316-322

Minor structural variations of benzomorphans opiates are associated with striking, unpredictable shifts in the relative extent of agonist or antagonist properties in vivo. The relative abilities of a number of benzomorphans in inhibit 3H-naloxone binding in the absence and presence of sodium in vitro show some correlations with their pharmacologic properties in vivo, although distinct exceptions exist. The ability of opiate agonists to inhibit 3H-naloxone binding is greatly reduced by sodium, while pure antagonists are affected very little, if at all, and mixed agonist-antagonist benzomorphans display an intermediate response.

(PDF emailed within 1 workday: $29.90)

Accession: 006036583

Download citation: RISBibTeXText

PMID: 1255479

Related references

Interacting ligand binding domains for neuroleptics and opiate benzomorphans on the haloperidol sensitive sigma opiate receptor. Society for Neuroscience Abstracts 13(3): 1703, 1987

Potential long acting opiate antagonists: preparation, pharmacological activity, and opiate-receptor binding of N-substituted 2'-hydroxy-5-methyl-9 alpha-propyl-6,7-benzomorphans. Journal of Pharmaceutical Sciences 66(2): 193-197, 1977

The opiate receptor binding interactions of opiate alkaloids and of an opioid peptide in rat brain membranes selection by manganese ions and by cholic acid sodium salt and minimalization of cross reaction in vitro. Molecular Pharmacology 21(3): 564-569, 1982

Studies on brain opiate receptor stability in vitro: inhibition of opiate receptor binding by adenosine-5'-diphosphate. Biochemical and Biophysical Research Communications 103(1): 189-195, 1981

Brain opiate receptor stability in vitro inhibition of opiate receptor binding by adenosine 5' di phosphate. Biochemical and Biophysical Research Communications 103(1): 189-195, 1981

Morphine-like peptides in mammalian brain: isolation, structure elucidation, and interactions with the opiate receptor. Proceedings of the National Academy of Sciences of the United States of America 73(7): 2515-2519, 1976

Studies on opiate transmission lines and on opiate monoamine interactions in the aged rat brain. Benedetti, C , C R Chapman And G Giron (Ed ) Advances in Pain Research And Therapy, Vol 14 Opioid Analgesia: Recent Advances in Systemic Administration; 5th World Congress on Pain, Venice, Italy, 1987 Xxvii+466p Raven Press: New York, New York, Usa Illus 107-120, 1990

The binding to rat brain homogenates of Mr2034, a universal opiate. Life Sciences 33(10): 985-991, 1983

A model for opiate-receptor interactions: mechanism of opiate-cerebroside sulfate interaction. Life Sciences 18(2): 231-244, 1976

Interactions of opiate k receptor agonists with opiate antagonists on the rabbit isolated vas deferens. British Journal of Pharmacology 76(SUPPL): 268P, 1982

A model system for opiate receptor interactions mechanism of opiate cerebroside sulfate interaction. Life Sciences 18(2): 231-244, 1976

Delta and kappa opiate receptors in primary astroglial cultures. Part II: Receptor sets in cultures from various brain regions and interactions with beta-receptor activated cyclic AMP. Neurochemical Research 17(6): 545-551, 1992

Reduction of opiate binding by factors present in the supernatant of mouse brain homogenates. Pharmacologist 22(3): 305, 1980

Interaction of phencyclidine like drugs and benzomorphans with the gaba receptor gated chloride channel in brain. Journal of Neurochemistry 52(SUPPL): S72, 1989